1. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-122549 Lophenol

Endogenous Metabolite

2026-06 Lophenol
HY-109137R Selgantolimod (Standard)

Reference Standards; Toll-like Receptor (TLR); HBV

Infection

2026-06 Selgantolimod (Standard)
HY-105801 Lydimycin

Bacterial

Infection

2026-06 Lydimycin
HY-109118AR Masupirdine mesylate (Standard)

Reference Standards; 5-HT Receptor

Neurological Disease

2026-06 Masupirdine mesylate (Standard)
HY-109106AR Upacicalcet sodium (Standard)

Reference Standards; CaSR

Endocrinology

2026-06 Upacicalcet sodium (Standard)
HY-109098R Parimifasor (Standard)

Reference Standards; ATP Synthase; Apoptosis

Inflammation/Immunology

2026-06 Parimifasor (Standard)
HY-109154R Obafistat (Standard)

Reference Standards; Others

Inflammation/Immunology

2026-06 Obafistat (Standard)
HY-109165AR Acoramidis hydrochloride (Standard)

Reference Standards; Transthyretin (TTR)

Metabolic Disease;

Endocrinology

2026-06 Acoramidis hydrochloride (Standard)
HY-109144R Enavogliflozin (Standard)

Reference Standards; SGLT

Metabolic Disease

2026-06 Enavogliflozin (Standard)
HY-109105R Tepilamide fumarate (Standard)

Reference Standards; Others

Inflammation/Immunology

2026-06 Tepilamide fumarate (Standard)
HY-109092R Licogliflozin (Standard)

Reference Standards; SGLT

Metabolic Disease;

Inflammation/Immunology

2026-06 Licogliflozin (Standard)
HY-10929R UNC0224 (Standard)

Reference Standards; Histone Methyltransferase

Cancer

2026-06 UNC0224 (Standard)
HY-10915R LUF6096 (Standard)

Reference Standards; Adenosine Receptor

Cardiovascular Disease

2026-06 LUF6096 (Standard)
HY-109168R Bersacapavir (Standard)

Reference Standards; HBV; DNA/RNA Synthesis

Infection

2026-06 Bersacapavir (Standard)
HY-109097R Otaplimastat (Standard)

Reference Standards; MMP; iGluR

Neurological Disease;

Inflammation/Immunology;

Cancer

2026-06 Otaplimastat (Standard)
HY-109143R Elsubrutinib (Standard)

Reference Standards; Btk

Inflammation/Immunology

2026-06 Elsubrutinib (Standard)
HY-109080R Belvarafenib (Standard)

Reference Standards; Raf

Cancer

2026-06 Belvarafenib (Standard)
HY-109136R Runcaciguat (Standard)

Reference Standards; Guanylate Cyclase

Metabolic Disease;

Cardiovascular Disease

2026-06 Runcaciguat (Standard)
HY-109127AR Berotralstat dihydrochloride (Standard)

Kallikrein; Reference Standards

Cardiovascular Disease;

Cancer

2026-06 Berotralstat dihydrochloride (Standard)
HY-109124AR Taniborbactam hydrochloride (Standard)

Reference Standards; Beta-lactamase; Bacterial

Infection

2026-06 Taniborbactam hydrochloride (Standard)